Press release
Dry Age-Related Macular Degeneration Clinical and Non-Clinical Studies, Key Companies, Therapeutic Assessment, Emerging Therapies, Treatment Algorithm, and Pipeline Analysis | Belite Bio, Inflammx Therapeutics, Ocugen, OliX Pharmaceuticals, Gensight Biolo
Dry Age-Related Macular Degeneration Pipeline Insights
Dry Age-Related Macular Degeneration Overview:
Age-related macular degeneration (AMD) is a degenerative condition affecting the central part of the retina (the macula), leading to gradual loss of central vision and significant disability for those affected. The term "age-related" indicates that the condition primarily occurs in older adults, while "macular" refers to damage in the macula. AMD typically affects individuals over 50 and was first documented over 80 years ago. It is one of the leading causes of blindness in the elderly and the primary cause of irreversible blindness in developed nations. Globally, approximately 170 million people are impacted by AMD, making it the third most common cause of vision loss worldwide. Dry AMD progresses slowly, while wet AMD can cause severe vision impairment in a short period. In the early stages, there are no noticeable symptoms, but an ophthalmologist may detect drusen long before any visual changes occur. In the intermediate stage, some individuals may notice slight vision changes, although many experience no symptoms at this point. Some people may see dark spots in the center of their vision or have trouble adjusting to changes in light levels.
Clinicians currently assess changes in the retina, retinal pigment epithelium (RPE), and choroid using a variety of imaging techniques, including fundus exams, color fundus photography, fluorescein angiography (FAF), optical coherence tomography (OCT), and infrared (IR) reflectance. Over the past two decades, OCT imaging has revolutionized the early detection, monitoring of disease progression, and assessment of treatment effectiveness for dry AMD. The current standard, spectral-domain OCT (SD-OCT), provides detailed, volumetric, and cross-sectional images of the retina, allowing for the visualization and monitoring of retinal layers, RPE, drusen, geographic atrophy (GA), and hyperreflective foci in dry AMD cases. While SD-OCT is the primary tool in clinical settings for diagnosing and predicting the progression of dry AMD, emerging technologies such as polarization-sensitive OCT (PS-OCT) may lead to significant changes in how dry AMD is imaged in both research and clinical practice.
Currently, no treatments are approved for dry AMD. Management primarily involves monitoring the condition, regular follow-up evaluations, and documentation to detect any decline in visual function and facilitate early intervention. Research is ongoing into various therapeutic approaches aimed at (1) preventing the disease, (2) halting its progression, and/or (3) restoring vision. Treatment options being explored include lifestyle and behavioral changes, supplements based on the Age-Related Eye Disease Study (AREDS), strategies to reduce toxic by-products, visual cycle modulators, anti-inflammatory agents, complement inhibitors, as well as gene therapy and cell-based therapies.
Request for a detailed insights report on Dry Age-Related Macular Degeneration pipeline insights @ https://www.delveinsight.com/report-store/dry-age-macular-degeneration-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
"Dry Age-Related Macular Degeneration Pipeline Insight 2024" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Dry Age-Related Macular Degeneration Therapeutics Market.
Key Takeaways from the Dry Age-Related Macular Degeneration Pipeline Report
DelveInsight's Dry Age-Related Macular Degeneration pipeline report depicts a robust space with 70+ active players working to develop 80+ pipeline therapies for Dry Age-Related Macular Degeneration treatment.
In June 2024, Stealth BioTherapeutics enrolled the first participant in the Phase III ReNEW clinical trial, which is part of a larger program to evaluate elamipretide as a treatment for dry age-related macular degeneration (AMD). This randomized, double-blind, placebo-controlled study will examine the efficacy, safety, and pharmacokinetics of daily subcutaneous injections of elamipretide.
Key Dry Age-Related Macular Degeneration companies such as Belite Bio, Inflammx Therapeutics, Ocugen, OliX Pharmaceuticals, Gensight Biologics, Alkeus Pharmaceuticals, Dobecure, Cognition Therapeutics, Aviceda Therapeutics, Galimedix Therapeutics, Mitotech, Annexon, Inc., NGM Biopharmaceuticals, Johnson & Johnson, Lineage Cell Therapeutics, Astellas Pharma, Regenerative Patch Technologies, Hoffmann-La Roche, Boehringer Ingelheim, ONL Therapeutics, and others are evaluating new drugs for Dry Age-Related Macular Degeneration to improve the treatment landscape.
Promising Dry Age-Related Macular Degeneration pipeline therapies in various stages of development include Tinlarebant (LBS-008), XIFLAM, OCU410, OLX301A, GS030, and others.
Dry Age-Related Macular Degeneration Pipeline Analysis
The report provides insights into:
The report provides detailed insights into the key companies that are developing therapies in the Dry Age-Related Macular Degeneration Market.
The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Dry Age-Related Macular Degeneration treatment.
It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
It navigates the emerging drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement of the Dry Age-Related Macular Degeneration market.
Download our free sample page report on Dry Age-Related Macular Degeneration pipeline insights @ https://www.delveinsight.com/sample-request/dry-age-macular-degeneration-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Dry Age-Related Macular Degeneration Emerging Drugs
Tinlarebant (LBS-008): Belite Bio
XIFLAM: Inflammx Therapeutics
OCU410: Ocugen
OLX301A: OliX Pharmaceuticals
GS030: Gensight Biologics
Dry Age-Related Macular Degeneration Companies
More than 70 prominent companies are actively developing treatments for Dry Age-related Macular Degeneration (Dry-AMD). Belite Bio is one such company, with its Dry-AMD drug candidates currently in the advanced Phase III stage.
DelveInsight's report covers around 80+ products under different phases of clinical development like
Late stage products (Phase III)
Mid-stage products (Phase II)
Early-stage product (Phase I) along with the details of
Pre-clinical and Discovery stage candidates
Discontinued & Inactive candidates
Dry Age-Related Macular Degeneration pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
Intravenous
Subcutaneous
Oral
Intramuscular
Dry Age-Related Macular Degeneration Products have been categorized under various Molecule types such as
Monoclonal antibody
Small molecule
Peptide
Download Sample Pages to Get an in-depth Assessment of the Emerging Dry Age-Related Macular Degeneration Therapies and Key Companies: Dry Age-Related Macular Degeneration Clinical Trials and advancements @ https://www.delveinsight.com/report-store/dry-age-macular-degeneration-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Dry Age-Related Macular Degeneration Pipeline Therapeutic Assessment
• Dry Age-Related Macular Degeneration Assessment by Product Type
• Dry Age-Related Macular Degeneration By Stage
• Dry Age-Related Macular Degeneration Assessment by Route of Administration
• Dry Age-Related Macular Degeneration Assessment by Molecule Type
Download Dry Age-Related Macular Degeneration Sample report to know in detail about the Dry Age-Related Macular Degeneration treatment market @ Dry Age-Related Macular Degeneration Therapeutic Assessment @ https://www.delveinsight.com/sample-request/dry-age-macular-degeneration-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Table of Content
1. Report Introduction
2. Executive Summary
3. Dry Age-Related Macular Degeneration Current Treatment Patterns
4. Dry Age-Related Macular Degeneration - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Dry Age-Related Macular Degeneration Late-Stage Products (Phase-III)
7. Dry Age-Related Macular Degeneration Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Dry Age-Related Macular Degeneration Discontinued Products
13. Dry Age-Related Macular Degeneration Product Profiles
14. Dry Age-Related Macular Degeneration Key Companies
15. Dry Age-Related Macular Degeneration Key Products
16. Dormant and Discontinued Products
17. Dry Age-Related Macular Degeneration Unmet Needs
18. Dry Age-Related Macular Degeneration Future Perspectives
19. Dry Age-Related Macular Degeneration Analyst Review
20. Appendix
21. Report Methodology
Request the Sample PDF to Get Detailed Insights About the Dry Age-Related Macular Degeneration Pipeline Reports Offerings: https://www.delveinsight.com/report-store/dry-age-macular-degeneration-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Contact Info:
Kritika Rehani
krehani@delveinsight.com
info@delveinsight.com
+14699457679
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Dry Age-Related Macular Degeneration Clinical and Non-Clinical Studies, Key Companies, Therapeutic Assessment, Emerging Therapies, Treatment Algorithm, and Pipeline Analysis | Belite Bio, Inflammx Therapeutics, Ocugen, OliX Pharmaceuticals, Gensight Biolo here
News-ID: 3828341 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Dry
Rising Prevalence Of Dry Eye Conditions Boosts Growth In Dry Eye Products Market …
The Dry Eye Products Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Dry Eye Products Market Size During the Forecast Period?
In recent years, there has been a significant expansion in the market size of dry eye products. The market is projected…
Dry Powder Inhalers Market - Breathe Freely: Dry Powder Inhalers Empowering Asth …
Newark, New Castle, USA: The "Dry Powder Inhalers Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Dry Powder Inhalers Market: https://www.growthplusreports.com/report/dry-powder-inhalers-market/8762
This latest report researches the industry structure,…
Dry Eye Market - Advancing Eye Wellness: Dry Eye Solutions Revolutionizing Relie …
Newark, New Castle, USA - new report, titled Dry Eye Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Dry Eye market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Dry Eye market. The report offers an overview of the market, which…
Dry Lubricants Market Size to Hit $ 813.78 Million by 2028 | Dry Lubricants Indu …
According to our experience research team, Dry Lubricants Market was valued at USD 755.42 Million in 2021, and the global Dry Lubricants industry is projected to reach a value of USD 813.78 Million by 2028, at a CAGR of 1.2% during the forecast period 2022-2028
The report is focused on gaining various Dry Lubricants market trends, dynamics, growth drivers, opportunities, weaknesses, strengths, and threats restraining the market growth. Further, the global…
Dry Ice Market In-Depth Analysis | Key Participants Dry Ice Corp., Dry Ice UK Lt …
Demand for dry ice is expected to magnify with the development of dry ice machines industry across the globe. Manufacturers in large multinational organizations and private firms have been contributing prominently in the revenue growth of dry ice market. Dry ice being a cost-effective product is expected to bolster its demand across various applications in the near future. Rising number of fire accidents leads to increasing demand for dry ice,…
Dry Screw Vacuum Pumps
Swam Dry vacuum pumps are the latest development in the vacuum pump industry. They offer a number of advantages over traditional vacuum pump designs. Best process gas blowers. There is “NO OIL / NO WATER” contact with the process vapours, which is why they are considered extremely environmentally friendly.
Visit us for more info - http://swamatics.com/ProductDetails.aspx?prod=Process%20Gas%20Blowers/Gas%20Boosters
The definition of a dry vacuum pump is a pump that does not use any…
